Induction Plus Adjuvant Chemotherapy, Combined Treatment with Nimotuzumab, and Intensity-Modulated Radiation Therapy for N3 Stage Nasopharyngeal Carcinoma
December 2021
in “
Journal of Cancer Research and Therapeutics
”
Studysummary In this study, induction nab-paclitaxel plus cisplatin, combined with nimotuzumab and IMRT, followed by S-1 adjuvant chemotherapy, showed excellent survival benefits with tolerable toxicities for stage N3 nasopharyngeal carcinoma patients.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on journals.lww.com →